Recent News
New EU Project: Personalised Health Blueprint to Prevent and Predict Inflammatory Bowel Disease
Click here for more informationread more
New Horizons in Bioinformatics
Lab Visit at the Huttenhower Lab, USA
Alba is associate scientist at the RU 5042 miTarget and doctoral researcher at the Institute of Clinical Molecular Biology (IKMB) / Kiel University (CAU). She received one of …read more
FEBS-IUBMB-ENABLE* Conference – The perfect opportunity to share experience and knowledge
16-18 November 2022, Seville, Spain
The full title of this conference was 1st International Molecular Biosciences PhD and Postdoc Conference: “THE PERFECT TANDEM: How technology expands the frontiers of biomedicine”. As its name says, most …read more
Horizons for doctoral researchers
Insights on gamma-delta T-cells / jobs for junior scientists in industry / feedback for doctoral projects
The 3rd Doc’s Day on November 04, 2022 was the first live event of the research unit miTarget …read more
Exploring metabolic relationships in symbioses
International symposium within the EU project SymbNET on microbiome metabolomics at Kiel University
From November 14-15, 2022, the Collaborative Research Center 1182 “Origin and Function of Metaorganisms” hosted an international symposium at Kiel University as …read more
Chronic inflammatory bowel diseases: Predicting the success of biologicals
An international team led by researchers from the Institute of Clinical Molecular Biology (IKMB) has found biomarkers that indicate at the beginning of anti-TNF alpha therapy whether it will be effective.
With chronic inflammatory bowel …read more
